There’s ever-increasing menu of tools, technologies and tactics to choose from, but is pharma ready to innovate?
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
Are the muddled laws and ethical questions surrounding privacy of genetic data impeding pharma research?
PharmaTimes Media is delighted to report that once again, clinical researchers from across the globe have engaged with the International Clinical Researcher of the Year competition.
Includes a special look at the pharmaceutical supply chain and strategic insights from Sanofi's UK and Ireland's Hugo Fry
Astellas UK’s membership of the Association of the British Pharmaceutical Industry has been suspended for a further 12 months because of a number of “serious breaches” of the Code of Practice.
23rd June 2017
AstraZeneca’s Daxas is now likely to be routinely available on the NHS to patients with chronic obstructive pulmonary disease (COPD), after new evidence helped persuade cost regulators that the drug is value for money in this setting.
23rd June 2017
US regulators have approved CSL Behring’s Haegarda, the first C1 esterase inhibitor for subcutaneous administration to prevent hereditary angioedema (HAE) attacks in adolescent and adults
23rd June 2017
Novartis’ combination therapy Tafinlar + Mekinist has won approval from the US Food and Drug Administration to treat patients with metastatic non-small cell lung cancer (NSCLC) carrying the BRAF V600E mutation.
23rd June 2017
NHS England is again issuing a call for the world’s “best healthcare innovations” to improve frontline patient care in a further round of the NHS Innovation Accelerator programme.
23rd June 2017
A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
How technology can help rather than hinder the human touch in clinical research
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
Improving the care of diabetes patients at City Hospitals Sunderland - a joint working initiative with Lilly
Engaging digital while retaining a human touch
Sanofi’s general manager for the UK and Ireland Hugo Fry on leading a company through transitional times
Richard Baderin, head of commercial enterprises at Accretio, on making the most of your resources
Laurence Woollard talks to PharmaTimes about life with a rare bleeding disorder
The pharmaceutical supply chain is facing both challenges and opportunities as the industry enters a new healthcare era 26 PharmaTimes
What does the nomination of Dr Scott Gottlieb mean for drug development and approval in the US?
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
